GenetikSignal Company
GenetikSignal was founded in 2011 as an anti-aging biotechnology company focusing on the mTOR signal transduction pathway. With the recent development of rapamycin analogs Everolimus and Temsirolimus targeting cell proliferation and FDA approval for metastatic breast cancer, there is excitement in the development of targeted therapies in this pathway for age-related diseases such as cancer and neurodegenerative diseases.
Founded Date:
01.08.2011
Last Funding Type:
N/A
Headquarters:
Rockville, USA
Technology:
Skin care preparations
Employee Number:
N/A
Industry:
Skin care
Estimated Revenue:
$0
Last Funding Date:
N/A
Funding Status:
N/A
Investor Type:
For Profit
Total Funding:
$0